Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema

NCT01095809 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped New intraocular steroid in the market. Recruitment no longer ethical.

Conditions

Uveitis

Interventions

DRUG: bevacizumab
DRUG: triamcinolone acetonide

Sponsor

Hospital Clinic of Barcelona